Showing results (611-620 of 708) with videos related to

Sort By:
Pageof 71
Journal of Experimental Botany|June 28, 2025
Phenotyping the hidden half: Combining UAV phenotyping and machine learning to predict barley root traits in the fieldSamir Alahmad, Daniel Smith, Christina Katsikis, et al.
Allergy|June 14, 2023
Spatial transcriptomics combined with single-cell RNA-sequencing unravels the complex inflammatory cell network in atopic dermatitisYasutaka Mitamura, Matthias Reiger, Juno Kim, et al.
The Journal of Allergy and Clinical Immunology|June 13, 2025
Transcriptomic profiling of vitiligo patients shows polar immune dysregulation in involved and uninvolved skinPatrick M Brunner, Eden David, Ester Del Duca, et al.
Experimental Dermatology|October 28, 2020
The erythema Q-score, an imaging biomarker for redness in skin inflammationJohn Frew, Lauren Penzi, Mayte Suarez-Farinas, et al.
EMBO Molecular Medicine|March 16, 2021
Psoriatic skin inflammation is promoted by c-Jun/AP-1-dependent CCL2 and IL-23 expression in dendritic cellsPhilipp Novoszel, Martin Holcmann, Gabriel Stulnig, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2018
Characteristics and Predictors for Secondary Leukemia and Myelodysplastic Syndrome in Ewing and Osteosarcoma SurvivorsNina N Sanford, Ruoyu Miao, Haotong Wang, et al.
Blood Advances|September 29, 2021
t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivitySarah B Mueller, Paola Dal Cin, Long P Le, et al.
Science Immunology|January 23, 2021
Persistence of mature dendritic cells, TH2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4Rα blockadeChristine Bangert, Katharina Rindler, Thomas Krausgruber, et al.
Leukemia Research|April 18, 2025
A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantationBrandon J Aubrey, Traci Blonquist, Malgorzata McMasters, et al.
Blood Advances|January 7, 2020
Clinical response to larotrectinib in adult Philadelphia chromosome-like ALL with cryptic ETV6-NTRK3 rearrangementValentina Nardi, Nora Ku, Matthew J Frigault, et al.
Pageof 71